2024-05-21 17:33:23 ET
Summary
- AVITA Medical specializes in regenerative medicine and has an innovative device for skin restoration that treats full-thickness skin defects and vitiligo.
- The RECELL device uses a patient's skin cells to create a spray-on suspension for healing and repigmentation. This procedure requires less donor skin and leads to faster wound recovery.
- RCEL's seemingly cheap P/S ratio is likely due to its operational inefficiency, which I don’t think will improve in the near term.
- Despite its innovative technology, I deem RCEL a "hold" due to financial concerns. Management needs to focus on achieving profitability to avoid dilution.
...
Read the full article on Seeking Alpha
For further details see:
AVITA Medical: Financial Challenges Ahead, Despite Innovative RECELL Device